Published 2019 | Version v1
Publication Metadata-only

Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients

Cattrini, Carlo
Rubagotti, Alessandra
Zinoli, Linda
Cerbone, Luigi
Zanardi, Elisa
Capaia, Matteo
Barboro, Paola
Boccardo, Francesco
Others:
Cattrini, Carlo
Rubagotti, Alessandra
Zinoli, Linda
Cerbone, Luigi
Zanardi, Elisa
Capaia, Matteo
Barboro, Paola
Boccardo, Francesco

Description

Circulating tumor cells (CTC), androgen receptor full-length (AR-FL), and androgen receptor splice variant 7 (AR-V7) are prognostic in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). AR-V7 seems to predict resistance to androgen-receptor signaling inhibitors (ARSi).

Additional details

Identifiers Origin repository
Created:
April 14, 2023
Modified:
November 28, 2023